Dyadic International, Inc. (DYAI)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 17, 2025

$1.50

P/E Ratio

N/A

Market Cap

$44.38M

Jan 30, 2024Mar 8, 2024Apr 10, 2024May 20, 2024Jun 21, 2024Jul 24, 2024Aug 27, 2024Oct 2, 2024Nov 4, 2024Dec 5, 2024Jan 20, 2025$0.00$10.00
  • PVT
Description

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.

Metrics

Overview

  • HQJupiter, FL
  • SectorHealth Services
  • IndustryMedical/Nursing Services
  • TickerDYAI
  • Price$1.5+0.67%

Trading Information

  • Market cap$44.38M
  • Float68.81%
  • Average Daily Volume (1m)167,803
  • Average Daily Volume (3m)102,238
  • EPS-$0.22

Company

  • Revenue$3.36M
  • Rev growth (1yr)393.00%
  • Net income-$0.20M
  • Gross margin79.78%
  • EBITDA margin-10.04%
  • EBITDA-$0.20M
  • EV$26.13M
  • EV/Revenue7.77
  • P/EN/A
  • P/S13.15
  • P/B13.01
Documents